Trials that use: Multiple imputation / missing data
New to this method? Read the tutorial →
7,624 results
- A Study for Patients With Type 2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of A Study for Patients With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01027871).
- A Study for the Assessment of the Benefits of a Novel Mesh Nebulizer in the Treatment of Patients With Stable COPD: Complete Statistical AnalysisIndependent statistical analysis of A Study for the Assessment of the Benefits of a Novel Mesh Nebulizer in the Treatment of Patients With Stable COPD: primary endpoint results, effect estimate with confidence…
- A Study for the Treatment of Diabetic Peripheral Neuropathic Pain: Complete Statistical AnalysisIndependent statistical analysis of A Study for the Treatment of Diabetic Peripheral Neuropathic Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00552175).
- A Study in Adults With Untreated Acute Lymphoblastic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of A Study in Adults With Untreated Acute Lymphoblastic Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00136435).
- A Study in Cancer Patients to Evaluate the Effect of Lapatinib on the QTc Interval: Complete Statistical AnalysisIndependent statistical analysis of A Study in Cancer Patients to Evaluate the Effect of Lapatinib on the QTc Interval: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Sulfonylurea With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-253): Complete Statistical AnalysisIndependent statistical analysis of A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Sulfonylurea With or Without Metformin in Participants With Type 2 Diabetes Mellitus…
- A Study in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria: Complete Statistical AnalysisIndependent statistical analysis of A Study in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Study in Dentinal Hypersensitivity (DH) Participants to Assess the Efficacy of an Occluding Dentifrice.: Complete Statistical AnalysisIndependent statistical analysis of A Study in Dentinal Hypersensitivity (DH) Participants to Assess the Efficacy of an Occluding Dentifrice.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Study in Healthy Japanese Men to Test How Different Doses of BI 1323495 Are Tolerated and How Itraconazole Influences the Amount of BI 1323495 in the Blood: Complete Statistical AnalysisIndependent statistical analysis of A Study in Healthy Japanese Men to Test How Different Doses of BI 1323495 Are Tolerated and How Itraconazole Influences the Amount of BI 1323495 in the Blood:…
- A Study in Healthy Men to Compare 2 Different Formulations of Alteplase: Complete Statistical AnalysisIndependent statistical analysis of A Study in Healthy Men to Compare 2 Different Formulations of Alteplase: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Study in Healthy Men to Test How BI 1265162 is Taken up and Processed by the Body: Complete Statistical AnalysisIndependent statistical analysis of A Study in Healthy Men to Test How BI 1265162 is Taken up and Processed by the Body: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- A Study in Healthy Men to Test How Different Doses of BI 474121 Are Taken up and How They Influence the Amount of a Molecular Messenger (cGMP) in the Spinal Fluid: Complete Statistical AnalysisIndependent statistical analysis of A Study in Healthy Men to Test How Different Doses of BI 474121 Are Taken up and How They Influence the Amount of a Molecular Messenger (cGMP) in…
- A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 706321 in the Blood: Complete Statistical AnalysisIndependent statistical analysis of A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 706321 in the Blood: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- A Study in Healthy Men to Test How the Body Takes up and Tolerates Different Doses of BI 474121, and Whether it Makes a Difference if BI 474121 is Taken as a Tablet or a Drink.: Complete Statistical AnalysisIndependent statistical analysis of A Study in Healthy Men to Test How the Body Takes up and Tolerates Different Doses of BI 474121, and Whether it Makes a Difference if BI 474121…
- A Study in Healthy Men to Test How Zongertinib (BI 1810631) is Taken up and Processed by the Body: Complete Statistical AnalysisIndependent statistical analysis of A Study in Healthy Men to Test How Zongertinib (BI 1810631) is Taken up and Processed by the Body: primary endpoint results, effect estimate with confidence interval, sample-size…
- A Study in Healthy Men to Test the Effects of Different Doses of BI 1467335 on MAO-B Activity in the Brain.: Complete Statistical AnalysisIndependent statistical analysis of A Study in Healthy Men to Test the Effects of Different Doses of BI 1467335 on MAO-B Activity in the Brain.: primary endpoint results, effect estimate with confidence…
- A Study in Healthy Men to Test Whether Food Affects the Amount of BI 894416 in the Blood: Complete Statistical AnalysisIndependent statistical analysis of A Study in Healthy Men to Test Whether Food Affects the Amount of BI 894416 in the Blood: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- A Study in Healthy Men to Test Whether Zongertinib Affects How 3 Other Medicines (Midazolam, Omeprazole, and Repaglinide) Are Taken up and Processed by the Body: Complete Statistical AnalysisIndependent statistical analysis of A Study in Healthy Men to Test Whether Zongertinib Affects How 3 Other Medicines (Midazolam, Omeprazole, and Repaglinide) Are Taken up and Processed by the Body: primary endpoint…
- A Study in Healthy People to Compare 2 Different Formulations of BI 1015550 Taken With or Without Food: Complete Statistical AnalysisIndependent statistical analysis of A Study in Healthy People to Compare 2 Different Formulations of BI 1015550 Taken With or Without Food: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- A Study in Healthy People to Compare How 2 Different Low Dose Formulations of BI 1015550 Are Taken up in the Body: Complete Statistical AnalysisIndependent statistical analysis of A Study in Healthy People to Compare How 2 Different Low Dose Formulations of BI 1015550 Are Taken up in the Body: primary endpoint results, effect estimate with…
- A Study in Healthy People to Test How BI 1015550 is Taken up in the Body When Given With or Without Food: Complete Statistical AnalysisIndependent statistical analysis of A Study in Healthy People to Test How BI 1015550 is Taken up in the Body When Given With or Without Food: primary endpoint results, effect estimate with…
- A Study in Healthy People to Test How BI 425809 is Taken up in the Body When Taken With or Without Food: Complete Statistical AnalysisIndependent statistical analysis of A Study in Healthy People to Test How BI 425809 is Taken up in the Body When Taken With or Without Food: primary endpoint results, effect estimate with…
- A Study in Healthy People to Test Whether BI 730357 Influences the Amount of Caffeine, Warfarin, Omeprazole, and Midazolam in the Blood: Complete Statistical AnalysisIndependent statistical analysis of A Study in Healthy People to Test Whether BI 730357 Influences the Amount of Caffeine, Warfarin, Omeprazole, and Midazolam in the Blood: primary endpoint results, effect estimate with…
- A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood: Complete Statistical AnalysisIndependent statistical analysis of A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood: primary endpoint results, effect estimate with confidence interval, sample-size…
- A Study In Japanese Healthy Male Volunteers To Investigate The Safety, Tolerability And Pharmacokinetics Of PF-02341066: Complete Statistical AnalysisIndependent statistical analysis of A Study In Japanese Healthy Male Volunteers To Investigate The Safety, Tolerability And Pharmacokinetics Of PF-02341066: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Study in Maintenance Kidney Transplant Recipients Following Conversion to Nulojix® (Belatacept)-Based: Complete Statistical AnalysisIndependent statistical analysis of A Study in Maintenance Kidney Transplant Recipients Following Conversion to Nulojix® (Belatacept)-Based: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Study in Participants With Acute Major Bleeding to Evaluate the Ability of Andexanet Alfa to Reverse the Anticoagulation Effect of Direct and Indirect Oral Anticoagulants (Extension Study): Complete Statistical AnalysisIndependent statistical analysis of A Study in Participants With Acute Major Bleeding to Evaluate the Ability of Andexanet Alfa to Reverse the Anticoagulation Effect of Direct and Indirect Oral Anticoagulants (Extension Study):…
- A Study in Participants With Diabetic Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of A Study in Participants With Diabetic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01113801).
- A Study In Patients With Neuropathic Pain From Diabetic Peripheral Neuropathy (DPN): Complete Statistical AnalysisIndependent statistical analysis of A Study In Patients With Neuropathic Pain From Diabetic Peripheral Neuropathy (DPN): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Study In Patients With Neuropathic Pain From Post-Herpetic Neuralgia (PHN): Complete Statistical AnalysisIndependent statistical analysis of A Study In Patients With Neuropathic Pain From Post-Herpetic Neuralgia (PHN): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Study in Patients With Rheumatoid Arthritis: Complete Statistical AnalysisIndependent statistical analysis of A Study in Patients With Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00966875).
- A Study Investigating the Effect of Montelukast in Patients With Seasonal Allergic Rhinitis (MK-0476-192)(COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of A Study Investigating the Effect of Montelukast in Patients With Seasonal Allergic Rhinitis (MK-0476-192)(COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Study of 2 Different Formulations of Insulin Lispro in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of A Study of 2 Different Formulations of Insulin Lispro in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Study of a Mastoid Device in Subjects With Ménière’s Disease: Complete Statistical AnalysisIndependent statistical analysis of A Study of a Mastoid Device in Subjects With Ménière's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Study of a Mobile Phone Application Measuring the Eyes Before and After Medication: Complete Statistical AnalysisIndependent statistical analysis of A Study of a Mobile Phone Application Measuring the Eyes Before and After Medication: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Study of a Novel Multi-Wavelength Laser for Tattoo Removal: Complete Statistical AnalysisIndependent statistical analysis of A Study of a Novel Multi-Wavelength Laser for Tattoo Removal: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02910505).
- A Study of a Single Dose of ALXN1210 in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of A Study of a Single Dose of ALXN1210 in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Study of A-101 Topical Solution in Subjects With Dermatosis Papulosa Nigra: Complete Statistical AnalysisIndependent statistical analysis of A Study of A-101 Topical Solution in Subjects With Dermatosis Papulosa Nigra: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Study of AA4500 in Men With Peyronie’s Disease: Complete Statistical AnalysisIndependent statistical analysis of A Study of AA4500 in Men With Peyronie's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01243411).
- A Study of Abemaciclib (LY2835219) Alone or in Combination With Other Agents in Participants With Previously Treated Pancreatic Ductal Adenocarcinoma: Complete Statistical AnalysisIndependent statistical analysis of A Study of Abemaciclib (LY2835219) Alone or in Combination With Other Agents in Participants With Previously Treated Pancreatic Ductal Adenocarcinoma: primary endpoint results, effect estimate with confidence interval,…
- A Study of Abemaciclib in Indian Women With Advanced Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Study of Abemaciclib in Indian Women With Advanced Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Study of Abemaciclib in Participants With Cancer That is Advanced or Has Spread to Another Part(s) of the Body: Complete Statistical AnalysisIndependent statistical analysis of A Study of Abemaciclib in Participants With Cancer That is Advanced or Has Spread to Another Part(s) of the Body: primary endpoint results, effect estimate with confidence interval,…
- A Study of Abemaciclib in Recurrent Glioblastoma: Complete Statistical AnalysisIndependent statistical analysis of A Study of Abemaciclib in Recurrent Glioblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02981940).
- A Study of ABI-H2158-containing Regimens in Participants With Chronic Hepatitis B Virus Infection: Complete Statistical AnalysisIndependent statistical analysis of A Study of ABI-H2158-containing Regimens in Participants With Chronic Hepatitis B Virus Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Study of Acetyl Hexapeptide-8 (AH8) in Treatment of Blepharospasm: Complete Statistical AnalysisIndependent statistical analysis of A Study of Acetyl Hexapeptide-8 (AH8) in Treatment of Blepharospasm: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00942851).
- A Study of Ad-RTS-hIL-12 + Veledimex in Pediatric Subjects With Brain Tumors Including DIPG: Complete Statistical AnalysisIndependent statistical analysis of A Study of Ad-RTS-hIL-12 + Veledimex in Pediatric Subjects With Brain Tumors Including DIPG: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Study of Ad26.COV2.S in Adults (COVID-19): Complete Statistical AnalysisIndependent statistical analysis of A Study of Ad26.COV2.S in Adults (COVID-19): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04436276).
- A Study of Adalimumab After Dose Escalation in Japanese Subjects With Crohn’s Disease: Complete Statistical AnalysisIndependent statistical analysis of A Study of Adalimumab After Dose Escalation in Japanese Subjects With Crohn's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Study of Adalimumab in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis: Complete Statistical AnalysisIndependent statistical analysis of A Study of Adalimumab in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Study of Adjuvant Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab for Resected High-Risk Melanoma in Participants With High-Risk Stage II-IV Melanoma (MK-7684A-010/KEYVIBE-010): Complete Statistical AnalysisIndependent statistical analysis of A Study of Adjuvant Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab for Resected High-Risk Melanoma in Participants With High-Risk Stage II-IV Melanoma (MK-7684A-010/KEYVIBE-010): primary endpoint results, effect estimate with confidence interval,…